We've come a long way, baby, but we still have a lot in common with the fruit fly. Exelixis, a pharmaceutical research and development firm, got its start analyzing genetic data from fruit flies and other organisms as a means to speed the development of drugs and other products. Its early genomic work has yielded a pipeline of drug candidates primarily in the area of cancer therapies, as well...